Persistent nodal histoplasmosis in nuclear factor kappa B essential modulator deficiency: Report of a case and review of infection in primary immunodeficiencies

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 3, 2016, Pages 903-905

  Lovell, Jana P ^a   Foruraghi, Ladan ^a   Freeman, Alexandra F ^a   Uzel, Gulbu ^a   Zerbe, Christa S ^a   Su, Helen ^a   Hsu, Amy P ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; FUNGUS ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; I KAPPA B KINASE GAMMA; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; POSACONAZOLE; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 2; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; AJELLOMYCES CAPSULATUS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; FUNGUS CULTURE; GENE MUTATION; HISTOPATHOLOGY; HISTOPLASMOSIS; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LYMPH NODE BIOPSY; MALE; MEDIASTINUM LYMPH NODE; MIDDLE AGED; PERSISTENT NODAL HISTOPLASMOSIS; PRIORITY JOURNAL; URINE; GENETICS; IMMUNOLOGY; MUTATION;

HISTOPLASMOSIS; HUMANS; I-KAPPA B KINASE; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MIDDLE AGED; MUTATION; NF-KAPPA B;

EID: 84971655049     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.02.040     Document Type: Article

References (9)

1. 1 Kauffman, C.A., Histoplasmosis. Clin Chest Med 30 (2009), 217–225.
2. 2 Grabbe, C., Husnjak, K., Dikic, I., The spatial and temporal organization of ubiquitin networks. Nat Rev Mol Cell Biol 12 (2011), 295–307.
3. 3 Courtois, G., Israël, A., IKK regulation and human genetics. Karin, M., (eds.) NF-kB in health and disease. Current topics in microbiology and immunology. Volume 349, 2011, Springer, Berlin, 73–95.
4. 4 Filipe-Santos, O., Bustamante, J., Haverkamp, M.H., Vinolo, E., Ku, C.L., Puel, A., et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 203 (2006), 1745–1759.
5. 5 Orange, J.S., Jain, A., Ballas, Z.K., Schneider, L.C., Geha, R.S., Bonilla, F.A., The presentation and natural history of immunodeficiency caused by nuclear factor kappa B essential modulator mutation. J Allergy Clin Immunol 113 (2004), 725–733.
6. 6 Braue, J., Murugesan, V., Holland, S., Patel, N., Naik, E., Leiding, J., et al. NF-kappa B essential modulator deficiency leading to disseminated cutaneous atypical mycobacteria. Mediterr J Hematol Infect Dis, 7, 2015, e2015010.
7. 7 Mihu, M.R., Nosanchuk, J.D., Histoplasma virulence and host responses. Int J Microbiol, 2012, 2012, 268123.
8. 8 Subramanian Vignesh, K., Landero Figueroa, J.A., Porollo, A., Caruso, J.A., Deepe, G.S. Jr., Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity 39 (2013), 697–710.
9. 9 Rhew, D.C., Goetz, M.B., Louie, M.H., Reversible CD4+ T lymphocyte depletion in a patient who had disseminated histoplasmosis and who was not infected with human immunodeficiency virus. Clin Infect Dis 21 (1995), 702–703.